
Quarterly report 2025-Q3
added 10-31-2025
The Bank of New York Mellon Corporation EBITDA 2011-2026 | BK
Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA), is an often used measure of a company's profitability. Financial analysts use EBITDA for a number of purposes including calculating simple valuations of a firm, estimating cash flows, and assessing debt servicing capability. The uses for EBITDA in financial analysis are numerous, but in practice should be more restrained. While EBITDA has some useful applications, it should be used with caution, as the problems with EBITDA are abundant and can lead to a number of misguided conclusions.[1]
EBITDA is an important indicator for investors and analysts because it allows them to evaluate a company's operating profit without considering the impact of financial expenses, taxes, or non-cash depreciation and amortization. It provides better comparability between companies in different industries or with different tax conditions.
EBITDA is often used to assess a company's ability to generate cash flow and repay debts. It can also serve as a measure of a company's operational efficiency, as it shows how profitable the core business is, regardless of external factors such as interest or taxes.
However, it is important to note that EBITDA is not an official financial statement measure and can be defined and calculated differently by companies. Therefore, investors and analysts should exercise caution when using EBITDA as an evaluation tool and combine it with other financial metrics and information to get a more complete picture of a company's financial condition.
Annual EBITDA The Bank of New York Mellon Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.8 B | 1.89 B | 1.78 B | 1.87 B | 1.63 B | 4.56 B | 4.45 B | 4.3 B | 3.78 B | 3.42 B | 2.86 B | 2.45 B | 2.83 B | 2.94 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.56 B | 1.63 B | 2.9 B |
Quarterly EBITDA The Bank of New York Mellon Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12 M | 11 M | 11 M | 13 M | 12 M | 13 M | 468 M | 14 M | 15 M | 14 M | 351 M | 16 M | 17 M | 17 M | 437 M | 19 M | 1.41 B | 20 M | 466 M | 26 M | 1.18 B | 744 M | 354 M | 28 M | 971 M | 635 M | 302 M | 35 M | 1.01 B | 677 M | 335 M | 52 M | 1.04 B | 693 M | 347 M | 60 M | 1.12 B | 748 M | 364 M | - | 1.08 B | 708 M | 340 M | 73 M | 976 M | 646 M | 333 M | 82 M | 1.05 B | 706 M | 333 M | 96 M | 911 M | 598 M | 299 M | 106 M | 557 M | 366 M | 183 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.41 B | 11 M | 405 M |
References
- Brockman, C. M., & Russell, J. W. (2012). EBITDA: use it... or lose it?. International Journal of Business, Accounting and Finance, 6(2), 84-93.
EBITDA of other stocks in the Diversified financials industry
| Issuer | EBITDA | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Altisource Asset Management Corporation
AAMC
|
247 K | - | -1.53 % | $ 3.77 M | ||
|
Ares Capital Corporation
ARCC
|
1.21 B | $ 20.49 | -0.75 % | $ 8.67 B | ||
|
Bain Capital Specialty Finance, Inc.
BCSF
|
22.4 K | $ 13.88 | -0.79 % | $ 896 M | ||
|
Арсагера
ARSA
|
-7.94 M | - | - | - | ||
|
Jupai Holdings Limited
JP
|
5.3 M | - | 0.98 % | $ 12.7 M | - | |
|
BlackRock
BLK
|
6.7 B | $ 1 089.91 | 0.47 % | $ 163 B | ||
|
Atlas Corp.
ATCO
|
1.13 B | - | -0.1 % | $ 4.45 B | ||
|
TCG BDC, Inc.
CGBD
|
158 M | $ 12.7 | -0.04 % | $ 699 M | ||
|
Ameriprise Financial
AMP
|
142 M | $ 510.81 | 0.56 % | $ 51.6 B | ||
|
МЕРИДИАН
MERF
|
-47.2 M | - | - | - | ||
|
Русс-Инвест
RUSI
|
12.4 M | - | - | - | ||
|
Сафмар
SFIN
|
10.6 B | - | - | - | ||
|
Capital Southwest Corporation
CSWC
|
5.86 M | $ 23.09 | 0.48 % | $ 1.1 B | ||
|
Daxor Corporation
DXR
|
-847 K | $ 13.82 | -2.6 % | $ 68.9 M | ||
|
BrightSphere Investment Group
BSIG
|
136 M | - | -0.11 % | $ 1.09 B | ||
|
The Blackstone Group
BX
|
98.8 M | $ 156.87 | -0.49 % | $ 120 B | ||
|
Ashford
AINC
|
36.2 M | - | 0.2 % | $ 15.3 M | ||
|
Equus Total Return, Inc.
EQS
|
-0.679 | $ 1.39 | 2.96 % | $ 18.8 M | ||
|
Great Elm Capital Corporation
GECC
|
36.5 | $ 7.14 | 1.28 % | $ 159 M | ||
|
Fidus Investment Corporation
FDUS
|
66.1 M | $ 19.71 | -0.5 % | $ 482 M | ||
|
Gladstone Capital Corporation
GLAD
|
15.2 M | $ 21.01 | 0.48 % | $ 652 M | ||
|
Cohen & Steers
CNS
|
182 M | $ 68.06 | 0.09 % | $ 3.43 B | ||
|
AssetMark Financial Holdings
AMK
|
35.5 M | - | - | $ 2.61 B | ||
|
FS KKR Capital Corp.
FSK
|
562 M | $ 14.47 | -0.75 % | $ 1.79 B | ||
|
Apollo Investment Corporation
AINV
|
-373 M | - | 0.52 % | $ 730 M | ||
|
CI Financial Corp
CIXX
|
937 M | - | -0.7 % | $ 2.9 B | - | |
|
Eaton Vance Corp.
EV
|
378 M | - | -0.98 % | $ 8.58 B | ||
|
Harvest Capital Credit Corporation
HCAP
|
-1.21 M | - | - | $ 57.7 M | ||
|
Medley Management Inc.
MDLY
|
-3.99 M | - | - | $ 18.3 M | ||
|
Puhui Wealth Investment Management Co., Ltd.
PHCF
|
-3.65 M | - | - | $ 5.54 M | ||
|
Puyi
PUYI
|
-68.5 M | - | 33.93 % | $ 811 M | ||
|
Hamilton Lane Incorporated
HLNE
|
7.44 M | $ 150.41 | 1.45 % | $ 3.95 B | ||
|
Waddell & Reed Financial, Inc.
WDR
|
107 M | - | -0.04 % | $ 1.55 B | ||
|
Tekla Healthcare Investors
HQH
|
-288 M | $ 19.07 | -1.55 % | $ 817 M | ||
|
The Carlyle Group
CG
|
184 M | $ 65.62 | 0.32 % | $ 23.5 B |